Indications for lowering platelet numbers in essential thrombocythemia
- 31 January 2003
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 40, 22-25
- https://doi.org/10.1053/shem.2003.50030
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Should a platelet limit of 600 × 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stagesBritish Journal of Haematology, 1998
- Interferon-α Therapy in Polycythemia Vera and Essential ThrombocythemiaSeminars in Thrombosis and Hemostasis, 1997
- Anagrelide as a New Platelet-Lowering Agent in Essential Thrombocythemia: Mechanism of Action, Efficacy, Toxicity, Current IndicationsSeminars in Thrombosis and Hemostasis, 1997
- Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisAmerican Journal of Hematology, 1996
- Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of ThrombosisNew England Journal of Medicine, 1995
- AnagrelideDrugs, 1994
- Interferon alpha-2b in the long-term treatment of essential thrombocythemiaAnnals of Hematology, 1991
- Interferon in essential thrombocythaemiaBritish Journal of Haematology, 1991
- Therapy of essential thrombocythemia with alpha‐interferon: Results and prospectsEuropean Journal of Haematology, 1990
- Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: Relationship to platelet number and functionEuropean Journal of Cancer and Clinical Oncology, 1983